The Effect of Remote Ischemic Preconditioning in the Cardiac Surgery (RIPC)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00997217|
Recruitment Status : Completed
First Posted : October 19, 2009
Last Update Posted : February 24, 2011
|Condition or disease||Intervention/treatment||Phase|
|Myocardium; Injury Cardiac Surgical Procedures||Procedure: remote ischemic preconditioning||Phase 1|
Perioperative myocardial injury is a serious complication of cardiac surgery. This complication increases both mortality and morbidity of cardiac surgery. Remote ischemic preconditioning (RIPC) is the concept that brief ischemia followed by reperfusion in an organ can reduce subsequent ischemia-reperfusion injury in distant organs. Recent several clinical trials showed powerful myocardial protective effect of remote ischemic preconditioning by reducing postoperative cardiac enzymes. However, the evidence that remote ischemic preconditioning can improve the clinical outcomes such as mortality and morbidity, is still lacking. The investigators perform a multicenter randomized controlled study to evaluate that remote ischemic preconditioning can improve the outcomes of cardiac surgery.
The purpose of this study is to examine if remote ischemic preconditioning can decrease the mortality and fatal postoperative complications in patients undergoing cardiac surgery. The effect will be assessed by mortality, severe morbidities and duration of hospital stay.
Study patients will be randomized to cardiac surgery with RIPC or conventional cardiac surgery in two cardiac surgical centers (Seoul National University Hospital and Asan Medical Center). Remote ischemic preconditioning consists of four 5 min cycles of upper limb ischemia and reperfusion with pneumatic cuff up to 200 mmHg. RIPC is performed twice: before and after the coronary anastomosis in off-pump coronary bypass graft surgery; or before and after the cardiopulmonary bypass in the cardiac valve surgery.
Primary study outcome is in-hospital death within 30 postoperative days and fatal postoperative complications such as myocardial infarction, stoke, respiratory failure, renal failure, cardiogenic shock and gastrointestinal complications. Secondary outcomes include the length of intensive care unit (ICU) stay and hospital stay.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||1200 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Triple (Participant, Care Provider, Investigator)|
|Official Title:||The Effect of Remote Ischemic Preconditioning on Mortality and Morbidity in Cardiac Surgery: a Randomized Controlled Trial|
|Study Start Date :||October 2009|
|Primary Completion Date :||September 2010|
|Study Completion Date :||November 2010|
Procedure: remote ischemic preconditioning
- In-hospital death [ Time Frame: Postoperative 30 days ]
- Myocardial infarction [ Time Frame: Postoperative 30 days ]
- Stroke [ Time Frame: Postoperative 30 days ]
- Respiratory failure [ Time Frame: Postoperative 30 days ]
- Renal dysfunction [ Time Frame: Postoperative 30 days ]
- Renal failure [ Time Frame: Postoperative 30 days ]
- Cardiogenic shock [ Time Frame: Postoperative 30 days ]
- Gastrointestinal complication [ Time Frame: Postoperative 30 days ]
- Length of ICU stay [ Time Frame: Postoperative 3 months ]
- Length of postoperative hospital stay [ Time Frame: Postoperative 3 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00997217
|Korea, Republic of|
|Seoul National University Hospital|
|Seoul, Korea, Republic of, 110-744|
|Study Director:||YunSeok Jeon, professor||Department of Anesthesiology and Pain Medicine, SNUH|